First Clinical Cases of OXA-48-Producing Klebsiella pneumoniae in Peru
Background: Carbapenemase-producing Enterobacteriaceae (CPE) represents a global public health concern and systemic infections associated with OXA-48 carbapenemase are increasingly being reported in Latin America. Here, we present the first 2 cases of systemic infections by OXA-48-Producing Klebsiel...
| Autores: | , , , , |
|---|---|
| Tipo de documento: | artigo |
| Estado: | Versão publicada |
| Data de publicação: | 2021 |
| País: | Perú |
| Recursos: | Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo |
| Repositório: | Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo |
| Idioma: | espanhol |
| OAI Identifier: | oai:cmhnaaa_ojs_cmhnaaa.cmhnaaa.org.pe:article/1260 |
| Acesso em linha: | https://cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/1260 |
| Access Level: | Acceso aberto |
| Palavra-chave: | Klebsiella Pneumoniae OXA-48 carbapenemasas Perú carbapenemases Peru |
| Resumo: | Background: Carbapenemase-producing Enterobacteriaceae (CPE) represents a global public health concern and systemic infections associated with OXA-48 carbapenemase are increasingly being reported in Latin America. Here, we present the first 2 cases of systemic infections by OXA-48-Producing Klebsiella pneumoniae in Peru. A favorable clinical response was observed after targeted treatment with colistin as a backbone. |
|---|